ID
29869
Beschrijving
Study ID: 102587 Clinical Study ID: EGF102587 Study Title: A Single-Dose, Open-Label, Randomized, Three-Way Cross-Over Study in Healthy Subjects to Evaluate the Relative Bioequivalence of Two New Small Tablet Formulations of Lapatinib (GW572016) Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tykerb,Tycerb,Tyverb; Tyverb,Tykerb,Tycerb Study Indication: Neoplasms, Breast Documentation part: Serious Adverse Event, Relevant Concomitant Treatment/Medications/Results
Trefwoorden
Versies (1)
- 24-04-18 24-04-18 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
24 april 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
GSK Study to Evaluate the Relative Bioequivalence of Two New Small Tablet Formulations of Lapatinib in Healthy Subjects 102587
Serious Adverse Event, Relevant Concomitant Treatment/Medications/Results
Beschrijving
Relevant medical conditions/Risk factors
Alias
- UMLS CUI-1
- C0262926
- UMLS CUI-2
- C0035648
- UMLS CUI-3
- C1519255
Beschrijving
MHx Sequence Number
Datatype
integer
Alias
- UMLS CUI [1]
- C2348184
Beschrijving
Specific Condition Name
Datatype
text
Alias
- UMLS CUI [1]
- C0012634
Beschrijving
Date of onset
Datatype
date
Alias
- UMLS CUI [1]
- C0574845
Beschrijving
Specific Condition Continuing
Datatype
integer
Alias
- UMLS CUI [1]
- C0012634
Beschrijving
Date of last occurrence
Datatype
date
Alias
- UMLS CUI [1,1]
- C2745955
- UMLS CUI [1,2]
- C0012634
- UMLS CUI [1,3]
- C0011008
Beschrijving
Relevant medical conditions/Risk factors
Datatype
text
Alias
- UMLS CUI [1]
- C0262926
- UMLS CUI [2]
- C0035648
Beschrijving
Relevant diagnostic results
Alias
- UMLS CUI-1
- C0430022
- UMLS CUI-2
- C0456984
- UMLS CUI-3
- C1519255
Beschrijving
Lab Sequence Number
Datatype
text
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C2348184
Beschrijving
Test Name
Datatype
text
Alias
- UMLS CUI [1]
- C0022885
Beschrijving
Test Date
Datatype
date
Alias
- UMLS CUI [1]
- C2826641
Beschrijving
Test Result
Datatype
text
Alias
- UMLS CUI [1]
- C0587081
Beschrijving
Test Units
Datatype
text
Alias
- UMLS CUI [1,1]
- C1519795
- UMLS CUI [1,2]
- C0587081
Beschrijving
Normal Low Range
Datatype
text
Alias
- UMLS CUI [1]
- C0086715
Beschrijving
Normal High Range
Datatype
text
Alias
- UMLS CUI [1]
- C0086715
Beschrijving
Relevant diagnostic results not noted above
Datatype
text
Alias
- UMLS CUI [1]
- C0587081
Beschrijving
event recurrence
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0034897
Similar models
Serious Adverse Event, Relevant Concomitant Treatment/Medications/Results
C0087111 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
C2347852 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0035648 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
C0012634 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0035648 (UMLS CUI [2])
C0456984 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
C2348184 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0034897 (UMLS CUI [1,3])